Taiyen Biotech Co Ltd (1737) — Capital Reinvestment Ratio
Taiyen Biotech Co Ltd (1737) has a Capital Reinvestment Ratio of 0.52x as of December 2025, meaning it reinvests 1% of its operating cash flow (NT$194.08 Million) in capital expenditures (NT$101.72 Million). See net asset quality index of Taiyen Biotech Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Taiyen Biotech Co Ltd Capital Reinvestment Ratio (2003–2025)
This chart tracks Taiyen Biotech Co Ltd's Capital Reinvestment Ratio across 23 annual periods. Check Taiyen Biotech Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year Capital Reinvestment Ratio for Taiyen Biotech Co Ltd from 2003 to 2025. For live market cap and broader valuation context, see market cap of Taiyen Biotech Co Ltd.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.63x | NT$473.77 Million | NT$300.16 Million | ▲ +36.0% |
| 2024 | 0.47x | NT$660.12 Million | NT$307.61 Million | ▼ -38.6% |
| 2023 | 0.76x | NT$454.54 Million | NT$345.13 Million | ▲ +78.8% |
| 2022 | 0.42x | NT$580.69 Million | NT$246.60 Million | ▼ -34.8% |
| 2021 | 0.65x | NT$600.08 Million | NT$390.81 Million | ▼ -17.5% |
| 2020 | 0.79x | NT$339.36 Million | NT$267.89 Million | ▼ -8.1% |
| 2019 | 0.86x | NT$330.81 Million | NT$284.25 Million | ▲ +29.5% |
| 2018 | 0.66x | NT$449.83 Million | NT$298.49 Million | ▲ +9.1% |
| 2017 | 0.61x | NT$607.87 Million | NT$369.68 Million | ▲ +81.5% |
| 2016 | 0.33x | NT$568.06 Million | NT$190.30 Million | ▲ +20.7% |
| 2015 | 0.28x | NT$383.93 Million | NT$106.57 Million | ▼ -30.8% |
| 2014 | 0.40x | NT$371.06 Million | NT$148.81 Million | ▼ -12.9% |
| 2013 | 0.46x | NT$203.21 Million | NT$93.53 Million | ▼ -35.0% |
| 2012 | 0.71x | NT$154.46 Million | NT$109.40 Million | ▲ +126.8% |
| 2011 | 0.31x | NT$246.09 Million | NT$76.85 Million | ▼ -25.5% |
| 2010 | 0.42x | NT$300.89 Million | NT$126.08 Million | ▲ +30.8% |
| 2009 | 0.32x | NT$358.02 Million | NT$114.67 Million | ▼ -30.4% |
| 2008 | 0.46x | NT$417.51 Million | NT$192.08 Million | ▲ +86.2% |
| 2007 | 0.25x | NT$322.49 Million | NT$79.70 Million | ▼ -22.9% |
| 2006 | 0.32x | NT$462.88 Million | NT$148.45 Million | ▲ +43.0% |
| 2005 | 0.22x | NT$575.91 Million | NT$129.19 Million | ▲ +229.6% |
| 2004 | 0.07x | NT$2.84 Billion | NT$192.93 Million | ▲ +146.5% |
| 2003 | 0.03x | NT$3.42 Billion | NT$94.39 Million | — |